Boussard & Gavaudan Holding Ltd (EUR): NAV(s)
January 26, 2017 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Solon Eiendom ASA : Primary insider notification - Cecilie Grue
January 26, 2017 01:30 ET
|
Solon Eiendom ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Solon Eiendom ASA STOCK EXCHANGE ANNOUNCEMENT ...
Ericsson reports fourth quarter and full year results 2016
January 26, 2017 01:30 ET
|
Telefonaktiebolaget LM Ericsson
FOURTH QUARTER HIGHLIGHTS Reported sales decreased by -11% YoY, with SEK -5.5 b. lower IPR licensing revenues.Despite strong sequential sales growth in Networks, the underlying market remained weak...
JOHNSON & JOHNSON TO ACQUIRE ACTELION FOR $30 BILLION WITH SPIN-OUT OF NEW R&D COMPANY
January 26, 2017 01:16 ET
|
Actelion Pharmaceuticals Ltd
For Immediate Release Actelion Shareholders to Receive $280 Per Actelion Share in All-Cash Tender Offer to be Launched by Johnson & Johnson and One Share of New R&D Company for Each...
Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report
January 26, 2017 01:15 ET
|
Novartis Pharma AG
Novartis Access-to-medicine programs reached approximately 52 million patients, including first-year deliveries through the innovative Novartis Access program Novartis improved position in key...
Alcon launches new trifocal toric intraocular lens for patients with astigmatism undergoing cataract surgery
January 26, 2017 01:10 ET
|
Novartis Pharma AG
Innovative AcrySof® IQ PanOptix® Toric intraocular lens (IOL) extends Alcon's trifocal PanOptix® IOL portfolio to a wider range of patients CE-marked in November 2016, this IOL offers...
ABLYNX'S PARTNER, MERCK KGaA, REPORTS ENCOURAGING RESULTS WITH THE BI-SPECIFIC NANOBODY ANTI-IL-17A/F (M1095) IN A PHASE Ib CLINICAL STUDY IN PATIENTS WITH PSORIASIS
January 26, 2017 01:09 ET
|
Ablynx NV
Primary objective of safety and tolerability met In the three highest dose groups, 100% of patients achieved a 75% or greater reduction in disease activity compared to 0% for placebo The onset of...
Höegh LNG : Sale of shares by Primary Insiders following Settlement of Round 1 of Management Stock Option Plan
January 26, 2017 01:00 ET
|
Höegh Lng As
Hamilton, Bermuda, 26 January 2017 - Reference is made to Höegh LNG Holdings Ltd.'s ("Höegh LNG" or the "Company") stock exchange notice dated 5 January 2017 where the Company informed about the share...
STMicroelectronics Reports 2016 Fourth Quarter and Full Year Financial Results
January 26, 2017 01:00 ET
|
STMicroelectronics N.V.
Fourth quarter net revenues up 3.5% sequentially and 11.5% year-over-year Fourth quarter gross margin of 37.5%, above our guidance, drives operating margin before impairment and...
EGIDE : Lancement d'une augmentation de capital avec maintien du DPS pour financer l'acquisition des actifs de la société américaine Santier LLC.
January 26, 2017 01:00 ET
|
EGIDE
Lancement d'une augmentation de capital de 7,15 millions d'euros avec maintien du droit préférentiel de souscription des actionnaires pour financer l'acquisition des actifs de la société américaine...